199 related articles for article (PubMed ID: 23924646)
21. Differences in alpha smooth muscle actin expression between fibroblasts derived from Dupuytren's nodules or cords.
Dave SA; Banducci DR; Graham WP; Allison GM; Ehrlich HP
Exp Mol Pathol; 2001 Oct; 71(2):147-55. PubMed ID: 11599921
[TBL] [Abstract][Full Text] [Related]
22. Periostin differentially induces proliferation, contraction and apoptosis of primary Dupuytren's disease and adjacent palmar fascia cells.
Vi L; Feng L; Zhu RD; Wu Y; Satish L; Gan BS; O'Gorman DB
Exp Cell Res; 2009 Dec; 315(20):3574-86. PubMed ID: 19619531
[TBL] [Abstract][Full Text] [Related]
23. IGF-II and IGFBP-6 regulate cellular contractility and proliferation in Dupuytren's disease.
Raykha C; Crawford J; Gan BS; Fu P; Bach LA; O'Gorman DB
Biochim Biophys Acta; 2013 Oct; 1832(10):1511-9. PubMed ID: 23623986
[TBL] [Abstract][Full Text] [Related]
24. The pathogenesis of Dupuytren's contracture: contractile mechanisms of the myofibroblasts.
Badalamente MA; Stern L; Hurst LC
J Hand Surg Am; 1983 May; 8(3):235-43. PubMed ID: 6683733
[TBL] [Abstract][Full Text] [Related]
25. The effect of interferon-alpha2b on an in vitro model Dupuytren's contracture.
Sanders JL; Dodd C; Ghahary A; Scott PG; Tredget EE
J Hand Surg Am; 1999 May; 24(3):578-85. PubMed ID: 10357539
[TBL] [Abstract][Full Text] [Related]
26. The different characteristics of Dupuytren's disease fibroblasts derived from either nodule or cord: expression of alpha-smooth muscle actin and the response to stimulation by TGF-beta1.
Bisson MA; McGrouther DA; Mudera V; Grobbelaar AO
J Hand Surg Br; 2003 Aug; 28(4):351-6. PubMed ID: 12849947
[TBL] [Abstract][Full Text] [Related]
27. Down-regulation of collagen synthesis and matrix metalloproteinase expression in myofibroblasts from Dupuytren nodule using adenovirus-mediated relaxin gene therapy.
Kang YM; Choi YR; Yun CO; Park JO; Suk KS; Kim HS; Park MS; Lee BH; Lee HM; Moon SH
J Orthop Res; 2014 Apr; 32(4):515-23. PubMed ID: 24293067
[TBL] [Abstract][Full Text] [Related]
28. Pharmacologic regulation of Dupuytren's fibroblast contraction in vitro.
Rayan GM; Parizi M; Tomasek JJ
J Hand Surg Am; 1996 Nov; 21(6):1065-70. PubMed ID: 8969433
[TBL] [Abstract][Full Text] [Related]
29. The presence of myofibroblasts in the dermis of patients with Dupuytren's contracture. A possible source for recurrence.
McCann BG; Logan A; Belcher H; Warn A; Warn RM
J Hand Surg Br; 1993 Oct; 18(5):656-61. PubMed ID: 8294839
[TBL] [Abstract][Full Text] [Related]
30. Cost-effectiveness in the management of Dupuytren's contracture. A Canadian cost-utility analysis of current and future management strategies.
Baltzer H; Binhammer PA
Bone Joint J; 2013 Aug; 95-B(8):1094-100. PubMed ID: 23908426
[TBL] [Abstract][Full Text] [Related]
31. Tamoxifen decreases fibroblast function and downregulates TGF(beta2) in dupuytren's affected palmar fascia.
Kuhn MA; Wang X; Payne WG; Ko F; Robson MC
J Surg Res; 2002 Apr; 103(2):146-52. PubMed ID: 11922728
[TBL] [Abstract][Full Text] [Related]
32. The chick chorioallantoic membrane: a model of short-term study of Dupuytren's disease.
Mîndrilă I; Pârvănescu H; Pirici D; Niculescu M; Buteică SA; Taisescu O; Tarnita DN
Rom J Morphol Embryol; 2014; 55(2):377-82. PubMed ID: 24969989
[TBL] [Abstract][Full Text] [Related]
33. Dupuytren's disease. A model for the mechanism of fibrosis and its modulation by steroids.
Meek RM; McLellan S; Crossan JF
J Bone Joint Surg Br; 1999 Jul; 81(4):732-8. PubMed ID: 10463754
[TBL] [Abstract][Full Text] [Related]
34. Intracellular actin as a marker for myofibroblasts in vitro.
Foo IT; Naylor IL; Timmons MJ; Trejdosiewicz LK
Lab Invest; 1992 Dec; 67(6):727-33. PubMed ID: 1460863
[TBL] [Abstract][Full Text] [Related]
35. Adiponectin inhibits fibrosis of the palmar aponeurosis in Dupuytren's contracture in male patients.
Yamanaka Y; Tajima T; Tsujimura Y; Naito T; Mano Y; Tsukamoto M; Zenke Y; Sakai A
Bone Joint Res; 2023 Aug; 12(8):486-493. PubMed ID: 37536684
[TBL] [Abstract][Full Text] [Related]
36. Microarray analysis of Dupuytren's disease cells: the profibrogenic role of the TGF-β inducible p38 MAPK pathway.
Ratkaj I; Bujak M; Jurišić D; Baus Lončar M; Bendelja K; Pavelić K; Kraljević Pavelić S
Cell Physiol Biochem; 2012; 30(4):927-42. PubMed ID: 22965824
[TBL] [Abstract][Full Text] [Related]
37. The pathobiology of Dupuytren's contracture: effects of prostaglandins on myofibroblasts.
Hurst LC; Badalamente MA; Makowski J
J Hand Surg Am; 1986 Jan; 11(1):18-23. PubMed ID: 3456001
[TBL] [Abstract][Full Text] [Related]
38. Extracorporeal shock waves modulate myofibroblast differentiation of adipose-derived stem cells.
Rinella L; Marano F; Berta L; Bosco O; Fraccalvieri M; Fortunati N; Frairia R; Catalano MG
Wound Repair Regen; 2016 Mar; 24(2):275-86. PubMed ID: 26808471
[TBL] [Abstract][Full Text] [Related]
39. Responsiveness of Dupuytren's disease fibroblasts to 5 alpha-dihydrotestosterone.
Pagnotta A; Specchia N; Soccetti A; Manzotti S; Greco F
J Hand Surg Am; 2003 Nov; 28(6):1029-34. PubMed ID: 14642522
[TBL] [Abstract][Full Text] [Related]
40. Dupuytren's Contracture: An Evidence Based Review.
Mella JR; Guo L; Hung V
Ann Plast Surg; 2018 Dec; 81(6S Suppl 1):S97-S101. PubMed ID: 30161050
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
